AGM/EGMJun 10, 2026, 05:26 PM
ImmunityBio Stockholders Re-elect Nine Directors at Annual Meeting
AI Summary
ImmunityBio, Inc. held its 2026 Annual Meeting of Stockholders on June 9, 2026. During the meeting, stockholders re-elected nine directors to serve a one-year term expiring at the 2027 annual meeting. Additionally, the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified. Approximately 85% of the outstanding shares were represented at the meeting.
Key Highlights
- Nine directors were re-elected to serve a one-year term expiring at the 2027 annual meeting.
- 885,167,059 shares of common stock, or approximately 85% of outstanding shares, were represented at the meeting.
- Patrick Soon-Shiong, M.D. was re-elected with 714,631,732 votes "For".
- Deloitte & Touche LLP was ratified as the independent registered public accounting firm for fiscal year 2026 with 882,420,139 votes "For".
- All director nominees received strong support, with "For" votes ranging from 714,631,732 to 732,149,734.
Price Impact
More from IBRX